DURHAM, N.C. & LIEGE, Belgium--(BUSINESS WIRE)--MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostics company in the field of personalized medicine, announced today that it has signed a lease agreement for a state-of-the-art laboratory and office facilities in Irvine, CA and has filed for CLIA certification of the US site. In addition, MDxHealth has filed for CLIA certification of its Liege facility.
